These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3326716)

  • 1. Recruitment experience in clinical trials: literature summary and annotated bibliography.
    Hunninghake DB; Darby CA; Probstfield JL
    Control Clin Trials; 1987 Dec; 8(4 Suppl):6S-30S. PubMed ID: 3326716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment for controlled clinical trials: literature summary and annotated bibliography.
    Lovato LC; Hill K; Hertert S; Hunninghake DB; Probstfield JL
    Control Clin Trials; 1997 Aug; 18(4):328-52. PubMed ID: 9257072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projection of participant recruitment to primary care research: a qualitative study.
    White D; Hind D
    Trials; 2015 Oct; 16():473. PubMed ID: 26482231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provider roles in the recruitment of underrepresented populations to cancer clinical trials.
    Howerton MW; Gibbons MC; Baffi CR; Gary TL; Lai GY; Bolen S; Tilburt J; Tanpitukpongse TP; Wilson RF; Powe NR; Bass EB; Ford JG
    Cancer; 2007 Feb; 109(3):465-76. PubMed ID: 17200964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving clinical trial accrual through a novel feedback approach: Lessons learned from a single disease site group.
    D'Alimonte L; Deabreu A; Marquez A; Mamedov A; Loblaw A
    Pract Radiat Oncol; 2015; 5(2):70-3. PubMed ID: 25413410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.
    Mileham KF; Kim ES
    Clin Cancer Res; 2016 Nov; 22(22):5397-5399. PubMed ID: 27601589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
    Pemberton VL; Evans F; Gulin J; Rosenberg E; Addou E; Burns KM; Gordon DJ; Pearson GD; Kaltman JR
    Clin Trials; 2018 Oct; 15(5):444-451. PubMed ID: 30084662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying results of randomised trials to clinical practice: impact of losses before randomisation.
    Charlson ME; Horwitz RI
    Br Med J (Clin Res Ed); 1984 Nov; 289(6454):1281-4. PubMed ID: 6437520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participant recruitment to the Coronary Primary Prevention Trial.
    J Chronic Dis; 1983; 36(6):451-65. PubMed ID: 6863469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to clinical trial recruitment in head and neck cancer.
    Haddad RI; Chan AT; Vermorken JB
    Oral Oncol; 2015 Mar; 51(3):203-11. PubMed ID: 25593017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruiting a special sample with sparse resources: lessons from a study of Gulf War veterans.
    Erickson LC; Ritchie JB; Javors JM; Golomb BA
    Clin Trials; 2013; 10(3):473-82. PubMed ID: 23325028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
    Paul K; Sathianathen N; Dahm P; Le C; Konety BR
    J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment and retention in obesity prevention and treatment trials targeting minority or low-income children: a review of the clinical trials registration database.
    Cui Z; Seburg EM; Sherwood NE; Faith MS; Ward DS
    Trials; 2015 Dec; 16():564. PubMed ID: 26651822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment and accrual of women in a randomized controlled trial of spinal manipulation.
    Cambron JA
    J Manipulative Physiol Ther; 2001 Feb; 24(2):79-83. PubMed ID: 11208219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning the duration of accrual and follow-up for clinical trials.
    Morgan TM
    J Chronic Dis; 1985; 38(12):1009-18. PubMed ID: 4066889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving enrollment in cancer clinical trials.
    Connolly NB; Schneider D; Hill AM
    Oncol Nurs Forum; 2004 May; 31(3):610-4. PubMed ID: 15146226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
    Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
    Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
    [No Abstract]   [Full Text] [Related]  

  • 19. Recruitment of participants for the multiple risk factor intervention trial (MRFIT).
    Neaton JD; Grimm RH; Cutler JA
    Control Clin Trials; 1987 Dec; 8(4 Suppl):41S-53S. PubMed ID: 3440389
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.